MPD: Phenotype measures associated with MP:0008469

Phenotype measures associated with
MP:0008469 'abnormal protein level'

This list also includes ontology descendants of MP:0008469. Or, you can show MP:0008469 only.

This MP term has been mapped to these MPD phenotype measurements to help users find relevant data. It should be noted that MPD measurements typically have a mixture of high-end, low-end and "normal" readings.

Data set	MPD ID	Procedure / Protocol	Drug or Challenge	Phenotype Measure	Panel	No. of Strains	Sex	Age	Sample Size (Avg)	Year
Cowell1	49001	hormone quantification	Staphylococcus aureus	fold-change in serum IL-6 levels 24h post-infection compared to controls [ratio] IL6	inbred	13	f	8wks	N=3	2012

Donahue9	41808	metabolic panel	(none)	alkaline phosphatase (serum ALP) [IU/L] ALP	B6.PWD consomic w/par	25	both	11wks	N=8	2011

Donahue9	41809	metabolic panel	(none)	alanine transaminase (serum ALT) [IU/L] ALT	B6.PWD consomic w/par	25	both	11wks	N=8	2011

Donahue9	41810	metabolic panel	(none)	aspartate transaminase (serum AST) [IU/L] AST	B6.PWD consomic w/par	25	both	11wks	N=8	2011

Donahue9	41814	metabolic panel	(none)	albumin (serum Alb) [g/dL] ALB	B6.PWD consomic w/par	25	both	11wks	N=8	2011

Donahue9	41816	metabolic panel	(none)	total protein (serum TP) [g/dL] TP	B6.PWD consomic w/par	25	both	11wks	N=8	2011

Eumorphia1	23901	metabolic panel	(none)	alanine transaminase (plasma ALT) [IU/L] ALT	inbred	4	both	12wks	N=20	2007

Eumorphia1	23902	metabolic panel	(none)	alkaline phosphatase (plasma ALP) [IU/L] ALP	inbred	4	both	12wks	N=30	2007

Eumorphia1	23903	metabolic panel	(none)	aspartate transaminase (plasma AST) [IU/L] AST	inbred	4	both	12wks	N=20	2007

Eumorphia1	23904	metabolic panel	(none)	creatine kinase (plasma CK) [IU/L] CK	inbred	4	both	12wks	N=34	2007

Eumorphia1	23917	metabolic panel	(none)	albumin (plasma Alb) [g/dL] ALB	inbred	6	both	12wks	N=17	2007

Eumorphia1	23918	metabolic panel	(none)	plasma alpha-amylase [IU/L] amylase	inbred	4	both	12wks	N=33	2007

Eumorphia1	23932	metabolic panel	(none)	total protein (plasma TP) [g/dL] total	inbred	6	both	12wks	N=27	2007

Farmer1	11333	immune cell quantification	(none)	percentage of Interleukin 12 in collected blood [%] IL12	QTL population		both	6wks	N=206	2001

Gros1	38503	genotype assessment	(none)	C5 allele (0=deficient, 1=sufficient) [designation] C5_allele	inbred	36	f	8-12wks	N=6	2011

Harrill1	39521	metabolic panel	isoniazid	alanine transaminase (serum ALT) [IU/L] control isoniazid	inbred	34	f	8-10wks	N=4	2011

Harrill2	44111	metabolic panel	DB289	alanine transaminase (serum ALT) [IU/L] control DB289 difference	inbred	34	f	6-8wks	N=5	2012

Jaxpheno3	22810	metabolic panel	(none)	albumin (plasma Alb) [g/dL] age 8wks age 16wks	inbred	11	both		N=16	2006

Jaxpheno3	22812	metabolic panel	(none)	total protein (plasma TP) [g/dL] age 8wks age 16wks	inbred	11	both		N=16	2006

Jaxpheno3	22815	metabolic panel	(none)	alanine transaminase (plasma ALT) [IU/L] age 8wks age 16wks	inbred	11	both		N=16	2006

Jaxpheno3	22817	metabolic panel	(none)	creatine kinase (plasma CK) [IU/L] age 8wks age 16wks	inbred	11	both		N=16	2006

Lake1	19929	metabolic panel	(none)	aspartate transaminase (plasma AST) [mg/dL] AST	B6.A consomic w/par	23	both	8wks	N=7	2005

Paigen1	2924	metabolic panel	high-fat diet	alanine transaminase (plasma ALT) [IU/L] ALT	inbred	43	both	15-19wks	N=8	2000

Paigen3	2824	metabolic panel	high-fat diet	alanine transaminase (plasma ALT) [IU/L] ALT	obesity mutants	8	both	15-19wks	N=16	2000

Peters1	6225	coagulation test	(none)	fibrinogen [mg/dL] Fib	inbred w/CC7	43	both	10wks	N=10	2001

Rice1	49201	proteomic profiling	(none)	2310061N02Rik protein, spectral counts, hair proteomics 2310061N02Rik	inbred	11	both	10-19wks	N=2	2012

Rice1	49202	proteomic profiling	(none)	ACGT1, spectral counts, hair proteomics Actg1	inbred	11	both	10-19wks	N=2	2012

Rice1	49203	proteomic profiling	(none)	ADH6B, spectral counts, hair proteomics Adh6b	inbred	11	both	10-19wks	N=2	2012

Rice1	49204	proteomic profiling	(none)	ASS1, spectral counts, hair proteomics Ass1	inbred	11	both	10-19wks	N=2	2012

Rice1	49205	proteomic profiling	(none)	CAPN12, spectral counts, hair proteomics Capn12	inbred	11	both	10-19wks	N=2	2012

Rice1	49206	proteomic profiling	(none)	CDSN, spectral counts, hair proteomics Cdsn	inbred	11	both	10-19wks	N=2	2012

Rice1	49207	proteomic profiling	(none)	CRISP1, spectral counts, hair proteomics Crisp1	inbred	11	both	10-19wks	N=2	2012

Rice1	49208	proteomic profiling	(none)	CTSB, spectral counts, hair proteomics Ctsb	inbred	11	both	10-19wks	N=2	2012

Rice1	49209	proteomic profiling	(none)	DSC2, spectral counts, hair proteomics Dsc2	inbred	11	both	10-19wks	N=2	2012

Rice1	49210	proteomic profiling	(none)	DUSP14, spectral counts, hair proteomics Dusp14	inbred	11	both	10-19wks	N=2	2012

Rice1	49211	proteomic profiling	(none)	EEF1A1, spectral counts, hair proteomics Eef1a1	inbred	11	both	10-19wks	N=2	2012

Rice1	49212	proteomic profiling	(none)	FABP4, spectral counts, hair proteomics Fabp4	inbred	11	both	10-19wks	N=2	2012

Rice1	49213	proteomic profiling	(none)	FABP5, spectral counts, hair proteomics Fabp5	inbred	11	both	10-19wks	N=2	2012

Rice1	49214	proteomic profiling	(none)	Gm11568, spectral counts, hair proteomics Gm11568	inbred	11	both	10-19wks	N=2	2012

Rice1	49217	proteomic profiling	(none)	HIST1H2BP, spectral counts, hair proteomics Hist1h2bp	inbred	11	both	10-19wks	N=2	2012

Rice1	49218	proteomic profiling	(none)	HIST1H4A, spectral counts, hair proteomics Hist1h4a	inbred	11	both	10-19wks	N=2	2012

Rice1	49219	proteomic profiling	(none)	KRT16, spectral counts, hair proteomics Krt16	inbred	11	both	10-19wks	N=2	2012

Rice1	49220	proteomic profiling	(none)	KRT17, spectral counts, hair proteomics Krt17	inbred	11	both	10-19wks	N=2	2012

Rice1	49221	proteomic profiling	(none)	KRT31, spectral counts, hair proteomics Krt31	inbred	11	both	10-19wks	N=2	2012

Rice1	49222	proteomic profiling	(none)	KRT32, spectral counts, hair proteomics Krt32	inbred	11	both	10-19wks	N=2	2012

Rice1	49223	proteomic profiling	(none)	KRT75, spectral counts, hair proteomics Krt75	inbred	11	both	10-19wks	N=2	2012

Rice1	49224	proteomic profiling	(none)	KRT81, spectral counts, hair proteomics Krt81	inbred	11	both	10-19wks	N=2	2012

Rice1	49225	proteomic profiling	(none)	KRT82, spectral counts, hair proteomics Krt82	inbred	11	both	10-19wks	N=2	2012

Rice1	49226	proteomic profiling	(none)	KRT83, spectral counts, hair proteomics Krt83	inbred	11	both	10-19wks	N=2	2012

Rice1	49227	proteomic profiling	(none)	KRT84, spectral counts, hair proteomics Krt84	inbred	11	both	10-19wks	N=2	2012

Rice1	49228	proteomic profiling	(none)	KRTAP3-2, spectral counts, hair proteomics Krtap3_2	inbred	11	both	10-19wks	N=2	2012

Rice1	49229	proteomic profiling	(none)	KRTAP4-6, spectral counts, hair proteomics Krtap4_6	inbred	11	both	10-19wks	N=2	2012

Rice1	49230	proteomic profiling	(none)	KRTAP6-2, spectral counts, hair proteomics Krtap6_2	inbred	11	both	10-19wks	N=2	2012

Rice1	49231	proteomic profiling	(none)	KRTAP11-1, spectral counts, hair proteomics Krtap11_1	inbred	11	both	10-19wks	N=2	2012

Rice1	49232	proteomic profiling	(none)	KRTAP13-1, spectral counts, hair proteomics Krtap13_1	inbred	11	both	10-19wks	N=2	2012

Rice1	49233	proteomic profiling	(none)	KRTAP14, spectral counts, hair proteomics Krtap14	inbred	11	both	10-19wks	N=2	2012

Rice1	49234	proteomic profiling	(none)	KRTAP15, spectral counts, hair proteomics Krtap15	inbred	11	both	10-19wks	N=2	2012

Rice1	49235	proteomic profiling	(none)	KRTAP16-1, spectral counts, hair proteomics Krtap16_1	inbred	11	both	10-19wks	N=2	2012

Rice1	49236	proteomic profiling	(none)	KRTAP19-1, spectral counts, hair proteomics Krtap19_1	inbred	11	both	10-19wks	N=2	2012

Rice1	49237	proteomic profiling	(none)	KRTAP19-3, spectral counts, hair proteomics Krtap19_3	inbred	11	both	10-19wks	N=2	2012

Rice1	49238	proteomic profiling	(none)	KRTAP19-4, spectral counts, hair proteomics Krtap19_4	inbred	11	both	10-19wks	N=2	2012

Rice1	49239	proteomic profiling	(none)	KRTAP19-5), spectral counts, hair proteomics Krtap19_5	inbred	11	both	10-19wks	N=2	2012

Rice1	49240	proteomic profiling	(none)	LGALS7, spectral counts, hair proteomics Lgals7	inbred	11	both	10-19wks	N=2	2012

Rice1	49241	proteomic profiling	(none)	ME1, spectral counts, hair proteomics Me1	inbred	11	both	10-19wks	N=2	2012

Rice1	49242	proteomic profiling	(none)	MLF1, spectral counts, hair proteomics Mlf1	inbred	11	both	10-19wks	N=2	2012

Rice1	49243	proteomic profiling	(none)	PKP1, spectral counts, hair proteomics Pkp1	inbred	11	both	10-19wks	N=2	2012

Rice1	49244	proteomic profiling	(none)	S100A3, spectral counts, hair proteomics S100a3	inbred	11	both	10-19wks	N=2	2012

Rice1	49245	proteomic profiling	(none)	SFN, spectral counts, hair proteomics Sfn	inbred	11	both	10-19wks	N=2	2012

Rice1	49246	proteomic profiling	(none)	TCHHL1, spectral counts, hair proteomics Tchhl1	inbred	11	both	10-19wks	N=2	2012

Rice1	49247	proteomic profiling	(none)	TUBB2A, spectral counts, hair proteomics Tubb2a	inbred	11	both	10-19wks	N=2	2012

Rice1	49248	proteomic profiling	(none)	VSIG8, spectral counts, hair proteomics Vsig8	inbred	11	both	10-19wks	N=2	2012

RIKEN-EAD1	37204	metabolic panel	(none)	alanine transaminase (plasma ALT) [IU/L] ALT	inbred RBRC	35	both	8wks	N=10	2008

RIKEN-EAD1	37205	metabolic panel	(none)	aspartate transaminase (plasma AST) [IU/L] AST	inbred RBRC	35	both	8wks	N=10	2008

RIKEN-EAD1	37207	metabolic panel	(none)	plasma amylase [U/L] amylase	inbred RBRC	35	both	8wks	N=10	2008

RIKEN-EAD1	37210	metabolic panel	(none)	albumin (plasma Alb) [g/dL] ALB	inbred RBRC	35	both	8wks	N=10	2008

RIKEN-EAD1	37212	metabolic panel	(none)	total protein (plasma TP) [g/dL] total	inbred RBRC	35	both	8wks	N=10	2008

RIKEN-EAD1	37229	metabolic panel	(none)	alkaline phosphatase (plasma ALP) [IU/L] ALP	inbred RBRC	35	both	8wks	N=10	2008

RIKEN-EAD2	37804	metabolic panel	(none)	alanine transaminase (plasma ALT) [IU/L] ALT	wild-derived RBRC	26	both	8wks	N=12	2008

RIKEN-EAD2	37805	metabolic panel	(none)	aspartate transaminase (plasma AST) [IU/L] AST	wild-derived RBRC	26	both	8wks	N=12	2008

RIKEN-EAD2	37807	metabolic panel	(none)	plasma amylase [U/L] amylase	wild-derived RBRC	26	both	8wks	N=12	2008

RIKEN-EAD2	37810	metabolic panel	(none)	albumin (plasma Alb) [g/dL] ALB	wild-derived RBRC	26	both	8wks	N=12	2008

RIKEN-EAD2	37812	metabolic panel	(none)	total protein (plasma TP) [g/dL] total	wild-derived RBRC	26	both	8wks	N=12	2008

RIKEN-EAD2	37829	metabolic panel	(none)	alkaline phosphatase (plasma ALP) [IU/L] ALP	wild-derived RBRC	26	both	8wks	N=12	2008

Rusyn2	36111	metabolic panel	(none)	alanine transaminase (serum ALT), naive [IU/L] ALT	inbred	16	m	7wks	N=3	2010

Rusyn2	36112	metabolic panel	trichloroethylene	alanine transaminase (serum ALT), control group [IU/L] time: 2h 8h 24h	inbred	16	m	7wks	N=3	2010

Rusyn2	36117	metabolic panel	trichloroethylene	alanine transaminase (serum ALT), treated group [IU/L] time: 2h 8h 24h	inbred	16	m	7wks	N=3	2010

Rusyn2	36121	metabolic panel	(none)	aspartate transaminase (serum AST), naive [IU/L] AST	inbred	15	m	7wks	N=3	2010

Rusyn2	36122	metabolic panel	trichloroethylene	aspartate transaminase (serum AST), control group [IU/L] time: 2h 8h 24h	inbred	15	m	7wks	N=3	2010

Rusyn2	36127	metabolic panel	trichloroethylene	aspartate transaminase (serum AST), treated group [IU/L] time: 2h 8h 24h	inbred	15	m	7wks	N=3	2010

Rusyn5	43001	metabolic panel	high-fat diet and ethanol	serum alanine transaminase (ALT) [IU/L] high-fat only high-fat and ethanol	inbred	14	m	8-14wks	N=3	2011

Rusyn5	43044	metabolite quantification	high-fat diet and ethanol	liver DDIT3 (formerly CHOP), protein expression relative to high-fat-only group [%] liver_DDIT3_hfe	inbred	14	m	8-14wks	N=3	2011

Rusyn5	43046	metabolite quantification	high-fat diet and ethanol	liver HSPA5 (formerly GRP78), protein expression relative to high-fat-only group [%] liver_HSPA5_hfe	inbred	14	m	8-14wks	N=3	2011

Rusyn5	43048	metabolite quantification	high-fat diet and ethanol	liver SREBF1 (formerly NSREBP1), protein expression relative to high-fat-only group [%] liver_SREBF1_hfe	inbred	14	m	8-14wks	N=3	2011

Rusyn6	51255	histopathology	trichloroethylene	kidney injury molecule 1 (KIM-1) positive proximal tubules [%] control TCE	inbred	7	m	6-7wks	N=4	2014

Shockley1	33404	metabolic panel	high-fat diet	glutamate dehydrogenase (GLDH) [IU/L] control diet high-fat diet difference	inbred	10	both	10-13wks	N=5	2008

Svenson3	27341	coagulation test	(none)	antithrombin III (AT III) anticlotting factor, percentage of normal human value [%] AT3	B6.PWD consomic w/par	22	both	6wks	N=8	2006

Svenson3	27342	coagulation test	(none)	clotting factor VIII, percent of normal human value [%] F8	B6.PWD consomic w/par	21	both	6wks	N=8	2006

Svenson3	27343	coagulation test	(none)	blood fibrinogen [mg/dL] Fib	B6.PWD consomic w/par	23	both	6wks	N=8	2006

Svenson3	27367	metabolic panel	(none)	aspartate transaminase (plasma AST) [mg/dL] AST	B6.PWD consomic w/par	21	both	8wks	N=7	2006

Threadgill1	19406	metabolic panel	acetaminophen	alanine transaminase (serum ALT) [IU/L] ALT_ctrl	inbred w/CC7	37	m	8-17wks	N=2	2005

Threadgill1	19407	metabolic panel	acetaminophen	alanine transaminase (serum ALT), t=4h [IU/L] ALT_Rx100_4h	inbred w/CC7	7	m	8-17wks	N=4	2005

Threadgill1	19408	metabolic panel	acetaminophen	alanine transaminase (serum ALT), t=12h [IU/L] ALT_Rx100_12h	inbred w/CC7	7	m	8-17wks	N=4	2005

Threadgill1	19409	metabolic panel	acetaminophen	alanine transaminase (serum ALT), t=24h [IU/L] ALT_Rx100_24h	inbred w/CC7	7	m	8-17wks	N=3	2005

Threadgill1	19410	metabolic panel	acetaminophen	aspartate transaminase (serum AST) [IU/L] dose (mg/kg): control 100 200 300	inbred w/CC7	37	m	8-17wks	N=2	2005

Threadgill1	19483	biomarker quantification	acetaminophen	cytochrome P450 1A2 isoform [pmol/mg] control post-Rx 300 mg/kg	inbred w/CC7	36	m	8-12wks	N=2	2005

Threadgill1	19484	biomarker quantification	acetaminophen	cytochrome P450 2E1 isoform [pmol/mg] control post-Rx 300 mg/kg	inbred w/CC7	37	m	8-12wks	N=2	2005

Threadgill2	39602	metabolic panel	acetaminophen	alanine transaminase (serum ALT) [IU/L] 50 mg/kg 300 mg/kg	inbred	5	m	6-8wks	N=5	2005

Tomasini1	26101	biomarker quantification	(none)	fibronectin [µg/mL] fibronectin	inbred	24	both	9wks	N=8	2007

Wiltshire3	38101	biomarker quantification	fluoxetine	cerebral cortex ACTH, relative fluorescence intensity control fluoxetine change index	inbred	30	m	10-11wks	N=3	2011

Wiltshire3	38104	biomarker quantification	fluoxetine	cerebral cortex APOD, relative fluorescence intensity control fluoxetine change index	inbred	30	m	10-11wks	N=3	2011

Wiltshire3	38107	biomarker quantification	fluoxetine	cerebral cortex BAG1, relative fluorescence intensity control fluoxetine change index	inbred	30	m	10-11wks	N=3	2011

Wiltshire3	38110	biomarker quantification	fluoxetine	cerebral cortex BDNF, relative fluorescence intensity control fluoxetine change index	inbred	30	m	10-11wks	N=3	2011

Wiltshire3	38113	biomarker quantification	fluoxetine	cerebral cortex CREB1 (CREB), relative fluorescence intensity control fluoxetine change index	inbred	30	m	10-11wks	N=3	2011

Wiltshire3	38116	biomarker quantification	fluoxetine	cerebral cortex FOS (c-fos), relative fluorescence intensity control fluoxetine change index	inbred	30	m	10-11wks	N=3	2011

Wiltshire3	38119	biomarker quantification	fluoxetine	cerebral cortex FUT9, relative fluorescence intensity control fluoxetine change index	inbred	30	m	10-11wks	N=3	2011

Wiltshire3	38122	biomarker quantification	fluoxetine	cerebral cortex GAD1 (GAD67), relative fluorescence intensity control fluoxetine change index	inbred	30	m	10-11wks	N=3	2011

Wiltshire3	38125	biomarker quantification	fluoxetine	cerebral cortex GAL, relative fluorescence intensity control fluoxetine change index	inbred	30	m	10-11wks	N=3	2011

Wiltshire3	38128	biomarker quantification	fluoxetine	cerebral cortex GFAP, relative fluorescence intensity control fluoxetine change index	inbred	30	m	10-11wks	N=3	2011

Wiltshire3	38131	biomarker quantification	fluoxetine	cerebral cortex GHRL, relative fluorescence intensity control fluoxetine change index	inbred	30	m	10-11wks	N=3	2011

Wiltshire3	38134	biomarker quantification	fluoxetine	cerebral cortex GIRK3 (KCNJ9), relative fluorescence intensity control fluoxetine change index	inbred	30	m	10-11wks	N=3	2011

Wiltshire3	38137	biomarker quantification	fluoxetine	cerebral cortex GLO1, relative fluorescence intensity control fluoxetine change index	inbred	30	m	10-11wks	N=3	2011

Wiltshire3	38140	biomarker quantification	fluoxetine	cerebral cortex GNB1, relative fluorescence intensity control fluoxetine change index	inbred	30	m	10-11wks	N=3	2011

Wiltshire3	38143	biomarker quantification	fluoxetine	cerebral cortex GRIN1 (NMDA1), relative fluorescence intensity control fluoxetine change index	inbred	30	m	10-11wks	N=3	2011

Wiltshire3	38146	biomarker quantification	fluoxetine	cerebral cortex GSK3B, relative fluorescence intensity control fluoxetine change index	inbred	30	m	10-11wks	N=3	2011

Wiltshire3	38149	biomarker quantification	fluoxetine	cerebral cortex GSR, relative fluorescence intensity control fluoxetine change index	inbred	30	m	10-11wks	N=3	2011

Wiltshire3	38152	biomarker quantification	fluoxetine	cerebral cortex HDAC5, relative fluorescence intensity control fluoxetine change index	inbred	30	m	10-11wks	N=3	2011

Wiltshire3	38155	biomarker quantification	fluoxetine	cerebral cortex NGF, relative fluorescence intensity control fluoxetine change index	inbred	30	m	10-11wks	N=3	2011

Wiltshire3	38158	biomarker quantification	fluoxetine	cerebral cortex NPY, relative fluorescence intensity control fluoxetine change index	inbred	30	m	10-11wks	N=3	2011

Wiltshire3	38161	biomarker quantification	fluoxetine	cerebral cortex P2RX7 (P2X7), relative fluorescence intensity control fluoxetine change index	inbred	30	m	10-11wks	N=3	2011

Wiltshire3	38164	biomarker quantification	fluoxetine	cerebral cortex PAQR8, relative fluorescence intensity control fluoxetine change index	inbred	30	m	10-11wks	N=3	2011

Wiltshire3	38167	biomarker quantification	fluoxetine	cerebral cortex PPP1R1B, relative fluorescence intensity control fluoxetine	inbred	30	m	10-11wks	N=3	2011

Wiltshire3	38170	biomarker quantification	fluoxetine	cerebral cortex PTH, relative fluorescence intensity control fluoxetine change index	inbred	30	m	10-11wks	N=3	2011

Wiltshire3	38173	biomarker quantification	fluoxetine	cerebral cortex S100B, relative fluorescence intensity control fluoxetine change index	inbred	30	m	10-11wks	N=3	2011

Wiltshire3	38176	biomarker quantification	fluoxetine	cerebral cortex SCG5 (SGNE), relative fluorescence intensity control fluoxetine change index	inbred	30	m	10-11wks	N=3	2011

Wiltshire3	38179	biomarker quantification	fluoxetine	cerebral cortex SLC6A2 (NET), relative fluorescence intensity control fluoxetine change index	inbred	30	m	10-11wks	N=3	2011

Wiltshire3	38182	biomarker quantification	fluoxetine	cerebral cortex SLC6A4 (SERT), relative fluorescence intensity control fluoxetine change index	inbred	30	m	10-11wks	N=3	2011

Wiltshire3	38185	biomarker quantification	fluoxetine	cerebral cortex SST, relative fluorescence intensity control fluoxetine change index	inbred	30	m	10-11wks	N=3	2011

Wiltshire3	38188	biomarker quantification	fluoxetine	cerebral cortex TNF (TNFa), relative fluorescence intensity control fluoxetine change index	inbred	30	m	10-11wks	N=3	2011

Wiltshire3	38191	biomarker quantification	fluoxetine	cerebral cortex VEGFA (VEGF), relative fluorescence intensity control fluoxetine change index	inbred	30	m	10-11wks	N=3	2011

Yuan3	24401	metabolic panel	(none)	alanine transaminase (plasma ALT) [IU/L] 6mo 12mo 18mo	inbred	29	both		N=6	2008

Yuan3	24411	metabolic panel	(none)	alkaline phosphatase (serum ALP) [IU/L] 6mo 12mo 18mo	inbred	28	both		N=7	2008

Yuan3	24451	metabolic panel	(none)	albumin (plasma Alb) [g/dL] 6mo 12mo 18mo	inbred	29	both		N=6	2008

Yuan3	24456	metabolic panel	(none)	total protein (plasma TP) [g/dL] 6mo 12mo 18mo	inbred	29	both		N=7	2008

Phenotype measures associated with MP:0008469 'abnormal protein level'

Phenotype measures associated with
MP:0008469 'abnormal protein level'